Response evaluation of SGLT2 inhibitor therapy in patients with type 2 diabetes mellitus using (18)F-FDG PET/MRI

INTRODUCTION: Inhibitors of sodium-glucose linked transporter-2 (SGLT2i) are enhancing glucose excretion in the proximal renal tubules, and thus are increasingly used to lower blood glucose levels in patients with type 2 diabetes mellitus (T2DM). The glucose analog 2-deoxy-2-((18)F) fluoro-D-glucose...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:BMJ Open Diabetes Res Care
Päätekijät: Rasul, Sazan, Geist, Barbara Katharina, Brath, Helmut, Baltzer, Pascal, Sundar, Lalith Kumar Shiyam, Pichler, Verena, Mitterhauser, Markus, Kautzky-Willer, Alexandra, Hacker, Marcus
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BMJ Publishing Group 2020
Aiheet:
Emerging Technologies, Pharmacology and Therapeutics
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7206902/
https://ncbi.nlm.nih.gov/pubmed/32205328
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjdrc-2019-001135
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia